Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic tool to detect and quantify coronary stenosis. Thanks to the rapid technological development, cardiac CT has become a comprehensive imaging modality which offers anatomical and functional information to guide patient management. This is the second of two complementary documents endorsed by the European Association of Cardiovascular Imaging aiming to give updated indications on the appropriate use of cardiac CT in different clinical scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation, are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic plaque, cardiomyopathies, structural heart disease, and congenital heart disease is revised.

Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II / G. Pontone, A. Rossi, M. Guglielmo, M.R. Dweck, O. Gaemperli, K. Nieman, F. Pugliese, P. Maurovich-Horvat, A. Gimelli, B. Cosyns, S. Achenbach. - In: EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING. - ISSN 2047-2412. - 23:4(2022 Apr), pp. e136-e161. [10.1093/ehjci/jeab292]

Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II

G. Pontone
Primo
;
2022

Abstract

Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic tool to detect and quantify coronary stenosis. Thanks to the rapid technological development, cardiac CT has become a comprehensive imaging modality which offers anatomical and functional information to guide patient management. This is the second of two complementary documents endorsed by the European Association of Cardiovascular Imaging aiming to give updated indications on the appropriate use of cardiac CT in different clinical scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation, are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic plaque, cardiomyopathies, structural heart disease, and congenital heart disease is revised.
CT perfusion imaging; FFRCT; artificial intelligence; cardiac computed tomography; cardiomyopathy; coronary computed tomography angiography (CCTA); fractional flow reserve; myocardial ischaemia; plaque imaging; radiomics; structural heart disease
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
apr-2022
17-feb-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
jeab292.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.3 MB
Formato Adobe PDF
2.3 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/954868
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 51
  • OpenAlex ND
social impact